Application 201593

Type
ANDA
Sponsor
TORRENT

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANTABLET;ORALEQ 5MG BASE;12.5MG;160MGNoNo
002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANTABLET;ORALEQ 5MG BASE;25MG;160MGNoNo
003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANTABLET;ORALEQ 10MG BASE;12.5MG;160MGNoNo
004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANTABLET;ORALEQ 10MG BASE;25MG;160MGNoNo
005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANTABLET;ORALEQ 10MG BASE;25MG;320MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A201593-001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANEQ 5MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03
A201593-002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANEQ 5MG BASE;25MG;160MGTABLET / ORAL2015-06-03
A201593-003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANEQ 10MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03
A201593-004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANEQ 10MG BASE;25MG;160MGTABLET / ORAL2015-06-03
A201593-005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANEQ 10MG BASE;25MG;320MGTABLET / ORAL2015-06-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 6 of 6 · 220 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10A201593-001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A201593-002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;25MG;160MGTABLET / ORAL2015-06-03f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A201593-003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A201593-004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;160MGTABLET / ORAL2015-06-03f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A201593-005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;320MGTABLET / ORAL2015-06-03f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A201593-001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03e64feba35796…
2022-09-29 23:25 UTC2022-09A201593-002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;25MG;160MGTABLET / ORAL2015-06-03e64feba35796…
2022-09-29 23:25 UTC2022-09A201593-003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03e64feba35796…
2022-09-29 23:25 UTC2022-09A201593-004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;160MGTABLET / ORAL2015-06-03e64feba35796…
2022-09-29 23:25 UTC2022-09A201593-005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;320MGTABLET / ORAL2015-06-03e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A201593-001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A201593-002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;25MG;160MGTABLET / ORAL2015-06-03cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A201593-003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A201593-004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;160MGTABLET / ORAL2015-06-03cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A201593-005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;320MGTABLET / ORAL2015-06-03cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A201593-001AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A201593-002AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 5MG BASE;25MG;160MGTABLET / ORAL2015-06-03a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A201593-003AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;12.5MG;160MGTABLET / ORAL2015-06-03a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A201593-004AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;160MGTABLET / ORAL2015-06-03a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A201593-005AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDEEQ 10MG BASE;25MG;320MGTABLET / ORAL2015-06-03a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A201593-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A201593-002AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A201593-003AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A201593-004AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A201593-005AB174a2ff9319b5…
2019-09-15 20:21 UTC2019-09A201593-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A201593-002AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A201593-003AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A201593-004AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A201593-005AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A201593-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A201593-002AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A201593-003AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A201593-004AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A201593-005AB1ea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13668-325Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-325Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-326Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-326Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-327Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-327Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-328Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-328Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-329Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
13668-329Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideTorrent Pharmaceuticals LimitedANDACurrent
70518-1220Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideREMEDYREPACK INC.ANDACurrent
70518-1220Amlodipine, Valsartan and HydrochlorothiazideAmlodipine, Valsartan and HydrochlorothiazideREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32121ORIG2015-06-10
32120ORIG2014-11-04